ONC:NASDAQ
BeOne Medicines AG
$350.40
arrow_downward
-1.15%(-4.07) 1D
$351.00
arrow_upward
+0.17% (+0.60)todayPre-market
Closed: Oct 12, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONC...
Open
$352.55
High
$354.15
Low
$346.61
Mkt. cap
42.40B
Avg. vol.
379.04K
Volume
679.00
52-wk high
$385.22
52-wk low
$253.95
Beta
0.61
Shares outstanding
109.79M
No. of employees
12K
Open
$352.55
High
$354.15
Low
$346.61
Mkt. cap
42.40B
Avg. vol.
379.04K
Volume
679.00
52-wk high
$385.22
52-wk low
$253.95
Beta
0.61
Shares outstanding
109.79M
No. of employees
12K
News stories
From web sources and news partners
Eagle-Tribune
·
19 minutes ago
XCF Global (Nasdaq:SAFX) Announces $12M+ in Gross Product Sales and Shipments of 1.4 Million Gallons of Renewable Diesel in September
Simply Wall Street
·
10 minutes ago
Should S&P 500 Addition Require Action From Twilio (TWLO) Investors?
24/7 Wall St.
·
36 minutes ago
Buffett Says a Know-Nothing Investor Can Beat the Pros. $250 a Month in the S&P 500 Could Turn Into $508,000
Yahoo Finance
·
27 minutes ago
S&P 500, Dow futures muted after big bank earnings, chip slide weighs
Profile
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market.
BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024, the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
About BeOne Medicines AG
CEOJohn Vincent Oyler | John Vincent Oyler
Employees12K
FoundedOct 28, 2010
Headquarters-
SectorBiotechnology
Websitebeonemedicines.com